Adelmidrol to fight upper airways inflammation in children: a pilot case control study to safety and efficacy
These preliminary results in our group of 60 children showed that Adelmidrol had the same efficacy of standard treatment when used as nasal spray only and was better than the standard treatment when used combining nasal and oral sprays. The molecule seems to offer the same benefit of standard treatment without side effects. If confirmed on a larger sample, the use of Adelmidrol could be suggested as an alternative to traditional treatment for the inflammation of URT in children.
Authors
- Pietro De Luca (ORCID: https://orcid.org/0000-0002-6505-1680)
- Arianna Di Stadio (ORCID: https://orcid.org/0000-0001-5510-3814)
- Antonio Della Volpe (ORCID: https://orcid.org/0000-0001-7241-8949)
- Chiara Bruno (ORCID: https://orcid.org/0000-0002-2506-4452)
- Massimo Ralli (ORCID: https://orcid.org/0000-0001-8776-0421)
Institutions
- Policlinico Umberto I (IT)
- Agostino Gemelli University Polyclinic (IT)
- Santobono Children's Hospital (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Sapienza University of Rome (IT)
Publication Details
- Journal
- European Archives of Oto-Rhino-Laryngology
- Published
- 2025-04-21
- DOI
- https://doi.org/10.1007/s00405-025-09375-z
- Citations
- 2
- Primary Topic
- Respiratory and Cough-Related Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04
Funders
- Università degli Studi della Campania Luigi Vanvitelli